Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA: a cancer journal for clinicians. 2008, 58 (2): 71-96. 10.3322/CA.2007.0010.
Google Scholar
Shiboski CH, Schmidt BL, Jordan RC: Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer. 2005, 103 (9): 1843-1849. 10.1002/cncr.20998.
Article
PubMed
Google Scholar
Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J, Creson N, Lindholm J, Ye W, Dalianis T, et al: Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. International journal of cancer. 2006, 119 (11): 2620-2623. 10.1002/ijc.22177.
Article
CAS
Google Scholar
zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nature reviews. 2002, 2 (5): 342-350. 10.1038/nrc798.
CAS
PubMed
Google Scholar
D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML: Case-control study of human papillomavirus and oropharyngeal cancer. The New England journal of medicine. 2007, 356 (19): 1944-1956. 10.1056/NEJMoa065497.
Article
PubMed
Google Scholar
Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, et al: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. Journal of the National Cancer Institute. 2000, 92 (9): 709-720. 10.1093/jnci/92.9.709.
Article
CAS
PubMed
Google Scholar
Gillison ML, Shah KV: Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Current opinion in oncology. 2001, 13 (3): 183-188. 10.1097/00001622-200105000-00009.
Article
CAS
PubMed
Google Scholar
Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. Journal of the National Cancer Institute. 2008, 100 (6): 407-420. 10.1093/jnci/djn025.
Article
PubMed
Google Scholar
Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, Klein W, Helbig M, Dietz A, Weidauer H, et al: Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer research. 1998, 58 (1): 5-13.
CAS
PubMed
Google Scholar
Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. Journal of the National Cancer Institute. 2008, 100 (4): 261-269. 10.1093/jnci/djn011.
Article
CAS
PubMed
Google Scholar
Dyson N, Howley PM, Munger K, Harlow E: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (New York, NY). 1989, 243 (4893): 934-937.
Article
CAS
Google Scholar
Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science (New York, NY). 1990, 248 (4951): 76-79.
Article
CAS
Google Scholar
Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM: Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2008, 14 (2): 366-369. 10.1158/1078-0432.CCR-07-1402.
Article
CAS
PubMed
Google Scholar
Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, et al: EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008, 26 (19): 3128-3137. 10.1200/JCO.2007.12.7662.
Article
PubMed Central
PubMed
Google Scholar
O'Regan EM, Toner ME, Finn SP, Fan CY, Ring M, Hagmar B, Timon C, Smyth P, Cahill S, Flavin R, et al: p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Human pathology. 2008, 39 (3): 452-458. 10.1016/j.humpath.2007.08.004.
Article
PubMed
Google Scholar
Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, et al: Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006, 24 (5): 736-747. 10.1200/JCO.2004.00.3335.
Article
CAS
PubMed
Google Scholar
Mroz EA, Baird AH, Michaud WA, Rocco JW: COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells. Cancer research. 2008, 68 (15): 6049-6053. 10.1158/0008-5472.CAN-08-1279.
Article
CAS
PubMed
Google Scholar
Nichols AC, Faquin WC, Westra WH, Mroz EA, Begum S, Clark JR, Rocco JW: HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2009, 140 (2): 228-234. 10.1016/j.otohns.2008.11.025.
Article
PubMed
Google Scholar
Gillison HJ, Westra W, Chung C, Jordan R, Rosenthal D, Nguyen-Tan P, Spanos WJ, Redmond KP, Ang K: Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129. J Clin Oncol. 2009, 27: 15s-10.1200/JCO.2008.21.7695.
Article
Google Scholar
Murata M, Takayama K, Choi BC, Pak AW: A nested case-control study on alcohol drinking, tobacco smoking, and cancer. Cancer detection and prevention. 1996, 20 (6): 557-565.
CAS
PubMed
Google Scholar
Spitz MR: Epidemiology and risk factors for head and neck cancer. Seminars in oncology. 1994, 21 (3): 281-288.
CAS
PubMed
Google Scholar
Charfi L, Jouffroy T, de Cremoux P, Le Peltier N, Thioux M, Freneaux P, Point D, Girod A, Rodriguez J, Sastre-Garau X: Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome. Cancer letters. 2008, 260 (1-2): 72-78. 10.1016/j.canlet.2007.10.028.
Article
CAS
PubMed
Google Scholar
Hafkamp HC, Manni JJ, Haesevoets A, Voogd AC, Schepers M, Bot FJ, Hopman AH, Ramaekers FC, Speel EJ: Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. International journal of cancer. 2008, 122 (12): 2656-2664. 10.1002/ijc.23458.
Article
CAS
Google Scholar
Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, Oggionni M, Rossini C, Cantu G, Squadrelli M, et al: High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006, 24 (36): 5630-5636. 10.1200/JCO.2005.04.6136.
Article
CAS
PubMed
Google Scholar
Ragin CC, Taioli E, Weissfeld JL, White JS, Rossie KM, Modugno F, Gollin SM: 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. British journal of cancer. 2006, 95 (10): 1432-1438. 10.1038/sj.bjc.6603394.
Article
PubMed Central
CAS
PubMed
Google Scholar
Reimers N, Kasper HU, Weissenborn SJ, Stutzer H, Preuss SF, Hoffmann TK, Speel EJ, Dienes HP, Pfister HJ, Guntinas-Lichius O, et al: Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. International journal of cancer. 2007, 120 (8): 1731-1738. 10.1002/ijc.22355.
Article
CAS
Google Scholar
Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X, Shyr Y, Murphy BM, Cmelak AJ, Burkey BB, et al: Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res. 2006, 12 (3 Pt 1): 701-709. 10.1158/1078-0432.CCR-05-2017.
Article
CAS
PubMed
Google Scholar
Smith EM, Wang D, Kim Y, Rubenstein LM, Lee JH, Haugen TH, Turek LP: P16INK4a expression, human papillomavirus, and survival in head and neck cancer. Oral oncology. 2008, 44 (2): 133-142. 10.1016/j.oraloncology.2007.01.010.
Article
CAS
PubMed
Google Scholar
Wittekindt C, Gultekin E, Weissenborn SJ, Dienes HP, Pfister HJ, Klussmann JP: Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival. Advances in oto-rhino-laryngology. 2005, 62: 72-80.
CAS
PubMed
Google Scholar
Kreimer AR, Clifford GM, Boyle P, Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005, 14 (2): 467-475. 10.1158/1055-9965.EPI-04-0551.
Article
CAS
PubMed
Google Scholar
Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, Campisi G: HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol. 2008, 19 (10): 1681-1690. 10.1093/annonc/mdn372.
Article
CAS
PubMed
Google Scholar
Ragin CC, Taioli E: Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. International journal of cancer. 2007, 121 (8): 1813-1820. 10.1002/ijc.22851.
Article
CAS
Google Scholar
Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ: Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006, 31 (4): 259-266. 10.1111/j.1749-4486.2006.01246.x.
Article
CAS
PubMed
Google Scholar
Li Y, Nichols MA, Shay JW, Xiong Y: Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer research. 1994, 54 (23): 6078-6082.
CAS
PubMed
Google Scholar
Klussmann JP, Gultekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, Eckel HE, Pfister HJ, Fuchs PG: Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. The American journal of pathology. 2003, 162 (3): 747-753.
Article
PubMed Central
CAS
PubMed
Google Scholar
Li W, Thompson CH, Cossart YE, O'Brien CJ, McNeil EB, Scolyer RA, Rose BR: The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head & neck. 2004, 26 (1): 1-9. 10.1002/hed.10335.
Article
Google Scholar
Rischin DYR, Fisher R, Fox S, Le Q, Peters L, Choi J, O'Sullivan B, Giralt J, McArthur G: Prognostic significance of HPV and p16 status in patients with oropharyngeal cancer treated on a large international phase III trial. J Clin Oncol. 2009, 27: 15s-10.1200/JCO.2008.21.7695.
Article
Google Scholar
Campisi G, Giovannelli L: Controversies surrounding Human Papilloma Virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment. Head & neck oncology. 2009, 1 (1): 8-10.1186/1758-3284-1-8.
Article
Google Scholar
Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J: Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck. J Clin Oncol. 2009, 27 (12): 1992-8. 10.1200/JCO.2008.20.2853.
Article
CAS
PubMed
Google Scholar
Kumar B, Cordell KG, Lee JS, Prince ME, Tran HH, Wolf GT, Urba SG, Worden FP, Chepeha DB, Teknos TN, et al: Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. International journal of radiation oncology, biology, physics. 2007, 69 (2 Suppl): S109-111.
Article
PubMed Central
CAS
PubMed
Google Scholar
Worden FP, Kumar B, Lee JS, Wolf GT, Cordell KG, Taylor JM, Urba SG, Eisbruch A, Teknos TN, Chepeha DB, et al: Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol. 2008, 26 (19): 3138-3146. 10.1200/JCO.2007.12.7597.
Article
PubMed Central
CAS
PubMed
Google Scholar
Cohen MA, Basha SR, Reichenbach DK, Robertson E, Sewell DA: Increased viral load correlates with improved survival in HPV-16-associated tonsil carcinoma patients. Acta oto-laryngologica. 2008, 128 (5): 583-589. 10.1080/00016480701558880.
Article
CAS
PubMed
Google Scholar
Worden HJ, Lee J, Eisbruch A, Wolf GT, Prince M, Moyer J, Teknos T, Chepeha DB, Bradford CR, Carey T: Association of tobacco (T) use with risk of distant metastases (DM), tumor recurrence, and death in patients (pts) with HPV-positive (+) squamous cell cancer of the oropharynx (SCCOP). J Clin Oncol. 2009, 27: 15s-10.1200/JCO.2008.21.7695.
Article
Google Scholar
Tran N, Rose BR, O'Brien CJ: Role of human papillomavirus in the etiology of head and neck cancer. Head & neck. 2007, 29 (1): 64-70. 10.1002/hed.20460.
Article
Google Scholar
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. The New England journal of medicine. 2007, 356 (19): 1915-1927. 10.1056/NEJMoa061741.
Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, et al: Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007, 369 (9580): 2161-2170. 10.1016/S0140-6736(07)60946-5.
Article
CAS
PubMed
Google Scholar
Chang Y, Brewer NT, Rinas AC, Schmitt K, Smith JS: Evaluating the impact of human papillomavirus vaccines. Vaccine. 2009, 27 (32): 4355-4362. 10.1016/j.vaccine.2009.03.008.
Article
CAS
PubMed
Google Scholar
Kim JJ, Goldie SJ: Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ (Clinical research ed). 2009, 339: b3884-10.1136/bmj.b3884.
Article
Google Scholar
Kim JJ, Ortendahl J, Goldie SJ: Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States. Annals of internal medicine. 2009, 151 (8): 538-545.
Article
PubMed Central
PubMed
Google Scholar